These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31192288)

  • 1. Carvedilol-Induced Liver Injury, a Rare Cause of Mixed Hepatitis: A Clinical Case.
    Rua J; Prata AR; Marques R; Silva R; Gomes B; Fraga J; Fortuna J
    GE Port J Gastroenterol; 2019 May; 26(3):196-201. PubMed ID: 31192288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic tolerance of atypical antipsychotic drugs].
    Dumortier G; Cabaret W; Stamatiadis L; Saba G; Benadhira R; Rocamora JF; Aubriot-Delmas B; Glikman J; Januel D
    Encephale; 2002; 28(6 Pt 1):542-51. PubMed ID: 12506267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
    Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
    Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Drug-induced Liver Injury.
    Devarbhavi H
    J Clin Exp Hepatol; 2012 Sep; 2(3):247-59. PubMed ID: 25755441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinic-epidemiological significance of drug hepatotoxicity in liver disease consultation].
    Jmelnitzky AC; Guidi M; Bologna A; Viola M; Soccini C; Barbero R; Belloni P; Apraiz M
    Acta Gastroenterol Latinoam; 2000; 30(2):77-84. PubMed ID: 10925723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatotoxicity associated with carvedilol.
    Hagmeyer KO; Stein J
    Ann Pharmacother; 2001 Nov; 35(11):1364-6. PubMed ID: 11724083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects.
    Ishak KG; Zimmerman HJ; Ray MB
    Alcohol Clin Exp Res; 1991 Feb; 15(1):45-66. PubMed ID: 2059245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats.
    Abdel-Kawy HS
    Drug Chem Toxicol; 2021 Jan; 44(1):101-111. PubMed ID: 30810389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiosyncratic drug hepatotoxicity: a 2008 update.
    Andrade RJ; López-Ortega S; López-Vega MC; Robles M; Cueto I; Lucena MI
    Expert Rev Clin Pharmacol; 2008 Mar; 1(2):261-76. PubMed ID: 24422651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver injury after methylprednisolone pulse therapy in multiple sclerosis is usually due to idiosyncratic drug-induced toxicity rather than autoimmune hepatitis.
    Kimura H; Takeda A; Kikukawa T; Hasegawa I; Mino T; Uchida-Kobayashi S; Ohsawa M; Itoh Y
    Mult Scler Relat Disord; 2020 Jul; 42():102065. PubMed ID: 32259746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiosyncratic drug-induced liver injury: an overview.
    Hussaini SH; Farrington EA
    Expert Opin Drug Saf; 2007 Nov; 6(6):673-84. PubMed ID: 17967156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.
    May LD; Lefkowitch JH; Kram MT; Rubin DE
    Ann Intern Med; 2002 Mar; 136(6):449-52. PubMed ID: 11900497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole Induced Recurrent Acute Toxic Hepatitis: A Case Report.
    Bilgic Y; Yilmaz C; Cagin YF; Atayan Y; Karadag N; Harputluoglu MMM
    Acta Gastroenterol Belg; 2017; 80(2):309-311. PubMed ID: 29560698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Cholestatic Liver Injury From Hydralazine Intake.
    Harati H; Rahmani M; Taghizadeh S
    Am J Ther; 2016; 23(5):e1211-4. PubMed ID: 26291593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kratom-Induced Cholestatic Liver Injury Mimicking Anti-Mitochondrial Antibody-Negative Primary Biliary Cholangitis: A Case Report and Review of Literature.
    Aldyab M; Ells PF; Bui R; Chapman TD; Lee H
    Gastroenterology Res; 2019 Aug; 12(4):211-215. PubMed ID: 31523332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escitalopram-induced hepatitis: A case report.
    Wabont G; Ferret L; Houdre N; Lepied A; Bene J; Cousein E
    World J Clin Cases; 2022 Mar; 10(8):2468-2473. PubMed ID: 35434055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of ceftriaxone-induced liver injury and literature review.
    Guarino M; Perna B; Pastorelli A; Bertolazzi P; Caio G; Maritati M; De Giorgio R; Contini C
    Infez Med; 2022; 30(2):293-297. PubMed ID: 35693049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydralazine-induced cholestatic hepatitis.
    Hassan A; Hammad R; Cucco R; Niranjan S
    Am J Ther; 2009; 16(4):371-3. PubMed ID: 19092641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.